- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00405158
Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding
A RCT in Sweden of Acupuncture and Care Interventions for the Relief of Inflammatory Symptoms of the Breast During Lactation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objectives: to further compare acupuncture treatment and care interventions for the relief of inflammatory symptoms of the breast during lactation and to investigate the relationship between bacteria in the breast milk and clinical signs and symptoms.
Design: randomised, non-blinded, controlled trial of acupuncture and care interventions.
Setting: a midwife-led breast-feeding clinic in Sweden.
Participants: 205 mothers with 210 cases of inflammatory symptoms of the breast during lactation agreed to participate. The mothers were randomly assigned to one of three treatment groups, two of which included acupuncture amongst the care interventions and one without acupuncture. All groups were given essential care. Protocols, which included scales for erythema, breast tension and pain, were maintained for each day of contact with the breast-feeding clinic. A Severity Index (SI) for each mother and each day was created by adding together the scores on the erythema, breast tension and pain scales. The range of the SI was 0 (least severe) to 19 (most severe).
Findings: There was no significant difference in numbers of mothers in the treatment groups with the lowest possible score for severity of symptoms on contact days 3, 4 or 5. There were no statistically significant differences between the treatment groups for number of contact days needed until the mother felt well enough to discontinue contact with the breast-feeding clinic or for number of mothers prescribed antibiotics. There were significant differences in the mean SI scores on contact days 3 and 4 between the non-acupuncture group and the two acupuncture groups. Mothers with less favourable outcomes (≥ 6 contact days, n = 61) were, at first contact with the midwife more often given advice on correction of the baby's attachment to the breast. An obstetrician was called to examine 20 % of the mothers and antibiotic therapy was prescribed for 15 % of the study population. The presence of Group B streptococci in the breast milk was related to less favourable outcomes.
Key conclusions and implications for practice: If acupuncture treatment is acceptable to the mother, this, together with care interventions such as correction of breast-feeding position and babies' attachment to the breast might be a more expedient and less invasive choice of treatment than the use of oxytocin nasal spray. Midwives, nurses or medical practitioners with specialist competence in breast feeding should be the primary care providers for mothers with inflammatory symptoms of the breast during lactation. The use of antibiotics for inflammatory symptoms of the breast should be closely monitored in order to help the global community reduce resistance development among bacterial pathogens.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Skane
-
Helsingborg, Skane, Sweden, 25187
- Dept Obstetrics & Gynecology, Helsingborg Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Lactating mothers with symptoms of breast inflammation
- Any mixture of increased breast tension, fever, breast erythema, lumps in the breast
Exclusion Criteria:
- Non-Swedish speaking
- Psychiatric illness
- Hemorrhagic disease
- Prosthetic heart valves
- Skin infections
- Hepatitis B
- HIV positive.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Proportion of women with lowest possible scores for symptom severity on days 3,4 and 5 in the three groups
|
|
Comparison of the three groups for mean scores for symptom severity on days 3,4 and 5
|
|
Comparison of the three treatment groups for number of contact days with health care services until recovery
|
|
Proportion of mothers in the three groups with less favourable outcomes (6 or more contact days to recovery)
|
|
Comparison of the three groups for proportions of women prescribed antibiotics
|
|
Comparison of the three groups for proportions of mothers who developed breast abscess
|
|
Proportions of women in the three groups who experienced residual symptoms within 6 weeks which required renewed health care contact
|
|
Comparison of the three groups for care interventions used
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Amounts of bacteria in the breast milk and correlated to erythema, increased breast tension and pain at first contact
|
|
Type of bacteria in breast milk related to favourable outcomes (5 or less contact days) and less favorable outcomes (6 or more contact days)
|
|
Differences in care interventions used in relation to favourable/less favourable outcomes
|
|
Relationship between the occurrence of residual symptoms and the use of antibiotics
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Linda J Kvist, PhD, Karlstads University
- Study Director: Bodil Wilde Larsson, PhD, Karlstad University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Skin Diseases
- Breast Diseases
- Pregnancy Complications
- Puerperal Disorders
- Mastitis
- Physiological Effects of Drugs
- Anti-Infective Agents
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Anti-Bacterial Agents
- Reproductive Control Agents
- Oxytocics
- Acetaminophen
- Oxytocin
- Floxacillin
- Penicillins
- Cefadroxil
- Antipyretics
Other Study ID Numbers
- 84839
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.